BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2665350)

  • 1. Oral cholera vaccines containing B-subunit-killed whole cells and killed whole cells only. II. Field evaluation of cross-protection against other members of the Vibrionaceae family.
    Clemens JD; Harris JR; Kay BA; Chakraborty J; Sack DA; Ansaruzzaman M; Rahman R; Stanton BF; Khan MU; Khan MR
    Vaccine; 1989 Apr; 7(2):117-20. PubMed ID: 2665350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral cholera vaccines containing B-subunit-killed whole cells and killed whole cells only. I. Cross-reacting antigens of members of family Vibrionaceae and the vaccines.
    Ciznăr I; Hussain N; Ahsan CR; Kay BA; Clemens JD; Sack DA
    Vaccine; 1989 Apr; 7(2):111-6. PubMed ID: 2750268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Field trial of oral cholera vaccines in Bangladesh.
    Clemens JD; Sack DA; Harris JR; Chakraborty J; Khan MR; Stanton BF; Kay BA; Khan MU; Yunus M; Atkinson W
    Lancet; 1986 Jul; 2(8499):124-7. PubMed ID: 2873397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exclusion of clinically atypical or microbiologically mixed diarrhoeal episodes from outcome events in a field trial of oral cholera vaccines.
    Clemens JD; Stanton BF; Harris JR; Chakraborty J; Sack DA; Rao MR; Ahmed F; Ansaruzzaman M; Yunus MD; Svennerholm AM
    Int J Epidemiol; 1989 Jun; 18(2):440-5. PubMed ID: 2767860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up.
    Clemens JD; Sack DA; Harris JR; Van Loon F; Chakraborty J; Ahmed F; Rao MR; Khan MR; Yunus M; Huda N
    Lancet; 1990 Feb; 335(8684):270-3. PubMed ID: 1967730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of B subunit killed whole-cell and killed whole-cell-only oral vaccines against cholera upon treated diarrhoeal illness and mortality in an area endemic for cholera.
    Clemens JD; Sack DA; Harris JR; Chakraborty J; Khan MR; Stanton BF; Ali M; Ahmed F; Yunus M; Kay BA
    Lancet; 1988 Jun; 1(8599):1375-9. PubMed ID: 2898052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.
    Bhattacharya SK; Sur D; Ali M; Kanungo S; You YA; Manna B; Sah B; Niyogi SK; Park JK; Sarkar B; Puri MK; Kim DR; Deen JL; Holmgren J; Carbis R; Dhingra MS; Donner A; Nair GB; Lopez AL; Wierzba TF; Clemens JD
    Lancet Infect Dis; 2013 Dec; 13(12):1050-6. PubMed ID: 24140390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired immune response to natural infection as a correlate of vaccine failure in a field trial of killed oral cholera vaccines.
    Clemens J; Rao M; Sack D; Ahmed F; Khan MR; Chakraborty J; Kay B; Huda S; Yunus M; van Loon F
    Am J Epidemiol; 1995 Oct; 142(7):759-64. PubMed ID: 7572947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Field trial of oral cholera vaccines in Bangladesh: results of one year of follow-up.
    Clemens JD; Harris JR; Sack DA; Chakraborty J; Ahmed F; Stanton BF; Khan MU; Kay BA; Huda N; Khan MR
    J Infect Dis; 1988 Jul; 158(1):60-9. PubMed ID: 3392421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam.
    Trach DD; Clemens JD; Ke NT; Thuy HT; Son ND; Canh DG; Hang PV; Rao MR
    Lancet; 1997 Jan; 349(9047):231-5. PubMed ID: 9014909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that inactivated oral cholera vaccines both prevent and mitigate Vibrio cholerae O1 infections in a cholera-endemic area.
    Clemens JD; Sack DA; Rao MR; Chakraborty J; Khan MR; Kay B; Ahmed F; Banik AK; van Loon FP; Yunus M
    J Infect Dis; 1992 Nov; 166(5):1029-34. PubMed ID: 1402014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial.
    Sur D; Lopez AL; Kanungo S; Paisley A; Manna B; Ali M; Niyogi SK; Park JK; Sarkar B; Puri MK; Kim DR; Deen JL; Holmgren J; Carbis R; Rao R; Nguyen TV; Donner A; Ganguly NK; Nair GB; Bhattacharya SK; Clemens JD
    Lancet; 2009 Nov; 374(9702):1694-702. PubMed ID: 19819004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of oral cholera vaccine as a vaccine probe to determine the burden of culture-negative cholera.
    Im J; Islam MT; Ahmmed F; Kim DR; Chon Y; Zaman K; Khan AI; Ali M; Marks F; Qadri F; Clemens JD
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007179. PubMed ID: 30870416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Field trial of oral cholera vaccines in Bangladesh: evaluation of anti-bacterial and anti-toxic breast-milk immunity in response to ingestion of the vaccines.
    Clemens JD; Sack DA; Chakraborty J; Rao MR; Ahmed F; Harris JR; van Loon F; Khan MR; Yunis M; Huda S
    Vaccine; 1990 Oct; 8(5):469-72. PubMed ID: 2251873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B subunit-whole cell and whole cell-only oral vaccines against cholera: studies on reactogenicity and immunogenicity.
    Clemens JD; Stanton BF; Chakraborty J; Sack DA; Khan MR; Huda S; Ahmed F; Harris JR; Yunus M; Khan MU
    J Infect Dis; 1987 Jan; 155(1):79-85. PubMed ID: 3540139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up.
    van Loon FP; Clemens JD; Chakraborty J; Rao MR; Kay BA; Sack DA; Yunus M; Ali M; Svennerholm AM; Holmgren J
    Vaccine; 1996 Feb; 14(2):162-6. PubMed ID: 8852414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial.
    Clemens JD; Sack DA; Harris JR; Chakraborty J; Neogy PK; Stanton B; Huda N; Khan MU; Kay BA; Khan MR
    J Infect Dis; 1988 Aug; 158(2):372-7. PubMed ID: 3042876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis.
    Ali M; Emch M; von Seidlein L; Yunus M; Sack DA; Rao M; Holmgren J; Clemens JD
    Lancet; 2005 Jul 2-8; 366(9479):44-9. PubMed ID: 15993232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.